Pen And Injector Drug Delivery Devices Market, By Product (Injectors and Pen), By Therapeutic Use, By End Use, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
|
Report ID
AV4779
|
Published Date
February 2026
|
Pages
321
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
The Pen And Injector Drug Delivery Devices Market size was valued at US$113,897.56 Million in 2024, expanding at a CAGR of 9.81% from 2025 to 2032.
Medical professionals use pen and injector drug delivery devices as specialized equipment that enables accurate administration of medications via subcutaneous or intramuscular injections while ensuring patient safety and precise dose control. These devices include both manual and electronic injection pens and autoinjectors, often prefilled with specific medications, which also allow patients to learn selfinjection at home. They are widely used for both chronic and acute conditions—such as diabetes, obesity, autoimmune disorders, hormonal deficiencies, and anaphylaxis—because these diseases require scheduled injections with exact dosing. Compared with traditional vialandsyringe methods, pen and injector devices improve dosing accuracy by reducing handling errors and minimizing pain and anxiety, thereby enhancing patient adherence in home care settings. This has led to their selection as preferred drug delivery systems for modern injectable treatments, including biologics and specialty pharmaceuticals. Globally, the pen and injector drug delivery devices market was valued at approximately USD115billion in 2025 and is projected to expand significantly through the coming decade, reflecting broad government and healthcare initiatives that support selfadministration, chronic disease management, and reduced hospitalization.Governments and health agencies across key regions are promoting the adoption of these devices to improve treatment compliance and reduce healthcare system burdens as chronic disease prevalence rises worldwide.
Pen And Injector Drug Delivery Devices Market- Market Dynamics
Increasing Prevalence of Chronic Diseases
The rising prevalence of chronic diseases is a key driver of market expansion for pen and injector drug delivery devices, as a growing number of patients require continuous and precise administration of injectable therapies. Individuals with conditions such as diabetes, obesity, autoimmune disorders, cardiovascular diseases, and hormonal imbalances depend on injectable medications to manage their health, creating sustained demand for userfriendly delivery systems. Pen and injector devices allow patients to selfadminister medications with accurate dosing, often yielding better treatment outcomes than traditional syringe methods—especially for those requiring lifelong therapy. These devices have become the preferred solution for home healthcare because they enable effective athome treatment, reduce the need for frequent hospital visits, and improve overall patient adherence and outcomes, thereby supporting market growth. Globally, noncommunicable chronic diseases now account for roughly 74% of all deaths, reflecting their vast health burden and importance in public health planning.According to the International Diabetes Federation, there were over 537million adults living with diabetes worldwide in 2023, a number expected to rise significantly in the coming decades, further driving demand for reliable injection devices that support chronic disease care.
Pen And Injector Drug Delivery Devices Market- Segmentation Analysis:
By Product
In 2024, the injector segment holds the largest share of the pen and injector drug delivery devices market. This growth is driven by patients with chronic conditions such as rheumatoid arthritis, multiple sclerosis, and diabetes, who increasingly seek user-friendly self-injection solutions for home treatment. Autoinjectors provide a simple, secure, and reliable delivery method, featuring hidden needles, automatic dosing mechanisms, and ergonomic designs that minimize user errors and reduce needle-associated pain. Global adoption of autoinjectors is rising as patients prefer self-administration, while advancements in biologic therapies are creating new opportunities for innovation. For instance, in October 2025, SCHOTT Pharma launched a 5.5ml large-volume prefillable staked-needle glass syringe through its syriQ BioPure platform. This syringe is compatible with Ypsomed’s YpsoMate 5.5 large-volume autoinjector, enabling patients to safely and conveniently administer biologic treatments at home. User-focused design and safety enhancements increase patient confidence and adherence, making the autoinjector segment a key area of focus for manufacturers and healthcare organizations alike.
Pen And Injector Drug Delivery Devices Market- Geographical Insights
The North American region is experiencing strong revenue growth in the pen and injector drug delivery devices market. The region’s advanced healthcare infrastructure, robust research and development capabilities, and innovative outcomes serve as key drivers of industry expansion. Market growth is further fueled by the high prevalence of chronic diseases such as diabetes and cancer. For example, breast cancer is among the most commonly diagnosed cancers in U.S. women, with over 310,000 new cases reported in 2024, according to the American Cancer Society. This underscores the need for reliable and user-friendly drug delivery methods.
The adoption of advanced devices is supported by government regulations and stringent quality standards established by organizations such as the U.S. Food and Drug Administration (FDA), which oversee prefilled pens and autoinjectors. In February 2025, the FDA approved the first rapid-acting insulin biosimilar, Merilog, available in both a 3ml prefilled pen and a 10ml multi-dose vial, demonstrating how regulatory support facilitates wider access to pen-based injectable therapies. Continued collaboration between pharmaceutical companies and regulatory authorities promotes innovation, enhances patient outcomes, and drives sustained market growth across North America.
Pen And Injector Drug Delivery Devices Market- Competitive Landscape:
The pen and injector drug delivery market is a competitive landscape shaped by two opposing forces. On one side are pharmaceutical companies that control their entire production processes, developing proprietary pen systems integrated with their exclusive drug portfolios. On the other side are specialized device manufacturers and contract manufacturers that provide precision-engineered solutions, custom components, and fill-finish capabilities. Major pharmaceutical companies, including Novo Nordisk, Eli Lilly, and Sanofi, dominate the market by combining high-demand biologics with proprietary pen systems. These companies rely on device manufacturers such as Becton Dickinson, Ypsomed, SHL Medical, West Pharmaceutical Services, and Gerresheimer for reusable and disposable platforms, fill-finish interfaces, and outsourced manufacturing services.
Market competition is driven by strategic partnerships, licensing agreements, and mergers and acquisitions, as pharmaceutical companies seek unique, user-friendly pen systems, including connected and electronic devices. Device manufacturers expand their product portfolios to secure long-term contracts with drugmakers. Pricing challenges persist, particularly in developing regions, due to demand uncertainty. Competition has intensified with growing demand for smart pens that offer data tracking and adherence monitoring, as well as the expanding adoption of GLP-1 pen products across multiple regions. This environment has created opportunities for mid-sized contract manufacturers to capture business from larger market players.
Recent Developments
-
In October 2025, Stevanato Group S.p.A. announced a major expansion of its drug delivery system manufacturing capacity in Germany, adding over 2,500m² of new production space at its Bad Oeynhausen facility. The expansion includes an ISO8 cleanroom for injection molding and automated assembly, strengthening the company’s presence in Europe and enhancing scalability, supply chain resilience, and support for both proprietary and contract manufacturing of autoinjector and pen injector platforms.
-
In September 2025, Apiject Systems Corp. submitted a New Drug Application to the U.S. FDA for the first injectable medicine delivered using its single-dose, single-use prefilled plastic syringe. The submission included glycopyrrolate, administered via Apiject’s specialized device, which combines Blow-Fill-Seal liquid packaging with precision-molded needle hubs. This platform enables scalable, cost-effective manufacturing using U.S.-sourced materials, providing an alternative to traditional glass vials and prefilled syringes.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL PEN AND INJECTOR DRUG DELIVERY DEVICES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Amgen, Inc.
- Merck KGaA
- Eli Lilly and Company
- AstraZeneca plc
- Pfizer, Inc.
- Sanofi
- Teva Pharmaceuticals
- Novo Nordisk A/S
- Ferring Pharmaceuticals
- AbbVie Inc.
GLOBAL PEN AND INJECTOR DRUG DELIVERY DEVICES MARKET, BY PRODUCT - MARKET ANALYSIS, 2019 - 2032
- Injectors
- GLP-1 Agonists
- Hormone Therapies
- Biologics
- Others
- Pen
- GLP-1 Agonists
- Insulin
- Hormone Therapies
- Others
GLOBAL PEN AND INJECTOR DRUG DELIVERY DEVICES MARKET, BY THERAPEUTIC USE - MARKET ANALYSIS, 2019 - 2032
- Autoimmune Disorders
- Diabetes Mellitus
- Oncology
- Obesity
- Hormonal Disorders
- Others
GLOBAL PEN AND INJECTOR DRUG DELIVERY DEVICES MARKET, BY END USE - MARKET ANALYSIS, 2019 - 2032
- Homecare Settings
- Hospitals
- Others
GLOBAL Pen And Injector Drug Delivery Devices MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Pen And Injector Drug Delivery Devices Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Pen And Injector Drug Delivery Devices Market Snippet by Product
2.1.2. Pen And Injector Drug Delivery Devices Market Snippet by Therapeutic Use
2.1.3. Pen And Injector Drug Delivery Devices Market Snippet by End Use
2.1.4. Pen And Injector Drug Delivery Devices Market Snippet by Country
2.1.5. Pen And Injector Drug Delivery Devices Market Snippet by Region
2.2. Competitive Insights
3. Pen And Injector Drug Delivery Devices Key Market Trends
3.1. Pen And Injector Drug Delivery Devices Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Pen And Injector Drug Delivery Devices Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Pen And Injector Drug Delivery Devices Market Opportunities
3.4. Pen And Injector Drug Delivery Devices Market Future Trends
4. Pen And Injector Drug Delivery Devices Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Pen And Injector Drug Delivery Devices Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Pen And Injector Drug Delivery Devices Market Landscape
6.1. Pen And Injector Drug Delivery Devices Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Pen And Injector Drug Delivery Devices Market – By Product
7.1. Overview
7.1.1. Segment Share Analysis, By Product, 2024&2032 (%)
7.1.2. Injectors
7.1.2.1. GLP-1 Agonists
7.1.2.2. Hormone Therapies
7.1.2.3. Biologics
7.1.2.4. Others
7.1.3. Pen
7.1.3.1. GLP-1 Agonists
7.1.3.2. Insulin
7.1.3.3. Hormone Therapies
7.1.3.4. Others
8. Pen And Injector Drug Delivery Devices Market – By Therapeutic Use
8.1. Overview
8.1.1. Segment Share Analysis, By Therapeutic Use, 2024&2032 (%)
8.1.2. Autoimmune Disorders
8.1.3. Diabetes Mellitus
8.1.4. Oncology
8.1.5. Obesity
8.1.6. Hormonal Disorders
8.1.7. Others
9. Pen And Injector Drug Delivery Devices Market – By End Use
9.1. Overview
9.1.1. Segment Share Analysis, By End Use, 2024&2032 (%)
9.1.2. Homecare Settings
9.1.3. Hospitals
9.1.4. Others
10. Pen And Injector Drug Delivery Devices Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2024&2032 (%)
10.2. North America
10.2.1. Overview
10.2.2. Pen And Injector Drug Delivery Devices Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
10.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
10.2.5. North America Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
10.2.6. North America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.2.7.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
10.2.7.4. U.S. Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
10.2.7.5. U.S. Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.2.8.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
10.2.8.4. Canada Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
10.2.8.5. Canada Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
10.3. Europe
10.3.1. Overview
10.3.2. Pen And Injector Drug Delivery Devices Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
10.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
10.3.5. Europe Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
10.3.6. Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.3.7.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
10.3.7.4. Germany Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
10.3.7.5. Germany Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
10.3.8. UK
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.3.8.3. UK Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
10.3.8.4. UK Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
10.3.8.5. UK Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
10.3.9. France
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.3.9.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
10.3.9.4. France Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
10.3.9.5. France Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
10.3.10. Italy
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.3.10.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
10.3.10.4. Italy Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
10.3.10.5. Italy Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
10.3.11. Spain
10.3.11.1. Overview
10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.3.11.3. Spain Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
10.3.11.4. Spain Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
10.3.11.5. Spain Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
10.3.12. The Netherlands
10.3.12.1. Overview
10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.3.12.3. The Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
10.3.12.4. The Netherlands Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
10.3.12.5. The Netherlands Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
10.3.13. Sweden
10.3.13.1. Overview
10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.3.13.3. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
10.3.13.4. Sweden Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
10.3.13.5. Sweden Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
10.3.14. Russia
10.3.14.1. Overview
10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.3.14.3. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
10.3.14.4. Russia Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
10.3.14.5. Russia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
10.3.15. Poland
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.3.15.3. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
10.3.15.4. Poland Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
10.3.15.5. Poland Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
10.3.16. Rest of Europe
10.3.16.1. Overview
10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.3.16.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
10.3.16.4. Rest of the Europe Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
10.3.16.5. Rest of the Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Pen And Injector Drug Delivery Devices Key Manufacturers in Asia Pacific
10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
10.4.4. APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
10.4.5. APAC Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
10.4.6. APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
10.4.7. China
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.4.7.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
10.4.7.4. China Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
10.4.7.5. China Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
10.4.8. India
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.4.8.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
10.4.8.4. India Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
10.4.8.5. India Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.4.9.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
10.4.9.4. Japan Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
10.4.9.5. Japan Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.4.10.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
10.4.10.4. South Korea Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
10.4.10.5. South Korea Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.4.11.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
10.4.11.4. Australia Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
10.4.11.5. Australia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
10.4.12. Indonesia
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.4.12.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
10.4.12.4. Indonesia Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
10.4.12.5. Indonesia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
10.4.13. Thailand
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.4.13.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
10.4.13.4. Thailand Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
10.4.13.5. Thailand Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.4.14.3. PhilippinesMarket Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
10.4.14.4. Philippines Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
10.4.14.5. Philippines Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.4.15.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
10.4.15.4. Rest of APAC Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
10.4.15.5. Rest of APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
10.5. Latin America (LATAM)
10.5.1. Overview
10.5.2. Pen And Injector Drug Delivery Devices Key Manufacturers in Latin America
10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
10.5.4. LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
10.5.5. LATAM Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
10.5.6. LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.5.7.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
10.5.7.4. Brazil Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
10.5.7.5. Brazil Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.5.8.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
10.5.8.4. Mexico Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
10.5.8.5. Mexico Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.5.9.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
10.5.9.4. Argentina Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
10.5.9.5. Argentina Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.5.10.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
10.5.10.4. Colombia Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
10.5.10.5. Colombia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
10.5.11.5. Rest of LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
10.6. Middle East and Africa (MEA)
10.6.1. Overview
10.6.2. Pen And Injector Drug Delivery Devices Key Manufacturers in Middle East and Africa
10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
10.6.4. MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
10.6.5. MEA Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
10.6.6. MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
10.6.7.5. Saudi Arabia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
10.6.8. UAE
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.6.8.3. UAE Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
10.6.8.4. UAE Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
10.6.8.5. UAE Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.6.9.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
10.6.9.4. Israel Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
10.6.9.5. Israel Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.6.10.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
10.6.10.4. Turkey Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
10.6.10.5. Turkey Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.6.11.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
10.6.11.4. Algeria Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
10.6.11.5. Algeria Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.6.12.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
10.6.12.4. Egypt Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
10.6.12.5. Egypt Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.6.13.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
10.6.13.4. Rest of MEA Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
10.6.13.5. Rest of MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
11. Key Vendor Analysis- Pen And Injector Drug Delivery Devices Industry
11.1. Competitive Dashboard
11.1.1. Competitive Benchmarking
11.1.2. Competitive Positioning
11.2. Company Profiles
11.2.1. Amgen, Inc.
11.2.2. Merck KGaA
11.2.3. Eli Lilly and Company
11.2.4. AstraZeneca plc
11.2.5. Pfizer, Inc.
11.2.6. Sanofi
11.2.7. Teva Pharmaceuticals
11.2.8. Novo Nordisk A/S
11.2.9. Ferring Pharmaceuticals
11.2.10. AbbVie Inc.
12. 360 Degree Analyst View
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL PEN AND INJECTOR DRUG DELIVERY DEVICES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Amgen, Inc.
- Merck KGaA
- Eli Lilly and Company
- AstraZeneca plc
- Pfizer, Inc.
- Sanofi
- Teva Pharmaceuticals
- Novo Nordisk A/S
- Ferring Pharmaceuticals
- AbbVie Inc.
GLOBAL PEN AND INJECTOR DRUG DELIVERY DEVICES MARKET, BY PRODUCT - MARKET ANALYSIS, 2019 - 2032
- Injectors
- GLP-1 Agonists
- Hormone Therapies
- Biologics
- Others
- Pen
- GLP-1 Agonists
- Insulin
- Hormone Therapies
- Others
GLOBAL PEN AND INJECTOR DRUG DELIVERY DEVICES MARKET, BY THERAPEUTIC USE - MARKET ANALYSIS, 2019 - 2032
- Autoimmune Disorders
- Diabetes Mellitus
- Oncology
- Obesity
- Hormonal Disorders
- Others
GLOBAL PEN AND INJECTOR DRUG DELIVERY DEVICES MARKET, BY END USE - MARKET ANALYSIS, 2019 - 2032
- Homecare Settings
- Hospitals
- Others
GLOBAL Pen And Injector Drug Delivery Devices MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
